Vanguard Group Inc Journey Medical Corp Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Journey Medical Corp stock. As of the latest transaction made, Vanguard Group Inc holds 325,171 shares of DERM stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
325,171
Previous 310,248
4.81%
Holding current value
$1.68 Million
Previous $1.75 Million
5.03%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DERM
# of Institutions
41Shares Held
2.94MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.46 Million0.36% of portfolio
-
Cambridge Investment Research Advisors, Inc.314KShares$1.62 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$1.38 Million0.0% of portfolio
-
American Financial Group Inc180KShares$928,8000.44% of portfolio
-
Pvg Asset Management Corp Golden, CO159KShares$818,0663.82% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $59.8M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...